Study finds calcium, vitamin D supplements may reduce cancer mortality in long term

by Elana GotkineFor postmenopausal women, calcium and vitamin D (CaD) supplements may reduce cancer mortality and increase cardiovascular disease (CVD) mortality after more than 20 years of follow-up,

Updated on: March 20,2024 20

Study finds calcium, vitamin D supplements may reduce cancer mortality in long term

by Elana GotkineFor postmenopausal women, calcium and vitamin D (CaD) supplements may reduce cancer mortality and increase cardiovascular disease (CVD) mortality after more than 20 years of follow-up,

Updated on:March 20,2024 20

Researcher puts focus on the health of Latina breast cancer survivors

by Katharine Gammon,University of Southern CaliforniaCredit: AI-generated imageBreast cancer is the leading cause of cancer death among Latinas in the United States. Latinas are also twice as li

Updated on: June 11,2024 7

Researcher puts focus on the health of Latina breast cancer survivors

by Katharine Gammon,University of Southern CaliforniaCredit: AI-generated imageBreast cancer is the leading cause of cancer death among Latinas in the United States. Latinas are also twice as li

Updated on:June 11,2024 7

Clinical trial shows efficacy for atezolizumab combined with carboplatin

byVanderbilt University Medical CenterCredit: CC0 Public DomainImmunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastati

Updated on: January 26,2024 12

Clinical trial shows efficacy for atezolizumab combined with carboplatin

byVanderbilt University Medical CenterCredit: CC0 Public DomainImmunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastati

Updated on:January 26,2024 12

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on: May 07,2024 13

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on:May 07,2024 13

Research provides insight into genetic link to potential treatment response among BRCA1/2 breast cancer patients

by Alex Gardner,Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainNew findings from researchers in the Perelman School of Medicine at the University of Pennsy

Updated on: June 01,2024 8

Research provides insight into genetic link to potential treatment response among BRCA1/2 breast cancer patients

by Alex Gardner,Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainNew findings from researchers in the Perelman School of Medicine at the University of Pennsy

Updated on:June 01,2024 8

Alternative glucose breakdown ensures the survival of cancer cells

byGerman Cancer Research CenterCredit: Pixabay/CC0 Public DomainA key enzyme in sugar metabolism is inactivated particularly easily and efficiently by oxidative stress. Scientists at the German

Updated on: January 07,2024 9

Alternative glucose breakdown ensures the survival of cancer cells

byGerman Cancer Research CenterCredit: Pixabay/CC0 Public DomainA key enzyme in sugar metabolism is inactivated particularly easily and efficiently by oxidative stress. Scientists at the German

Updated on:January 07,2024 9

Trial shows promise for new antibody cancer treatment

byKing's College LondonMechanism of cytotoxicity mediated by MOv18 IgE. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-39679-9The first ever clinical trial of a new

Updated on: January 04,2024 10

Trial shows promise for new antibody cancer treatment

byKing's College LondonMechanism of cytotoxicity mediated by MOv18 IgE. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-39679-9The first ever clinical trial of a new

Updated on:January 04,2024 10

Treating Alzheimer's, Parkinson's, type 2 diabetes by eliminating protein aggregation in brain, pancreas

by Steve Martin,Purdue UniversityCredit: Wikimedia CommonsPurdue University researchers have taken the first steps to treat Alzheimer's disease, Parkinson's disease and Type 2 diabetes b

Updated on: May 06,2024 14

Treating Alzheimer's, Parkinson's, type 2 diabetes by eliminating protein aggregation in brain, pancreas

by Steve Martin,Purdue UniversityCredit: Wikimedia CommonsPurdue University researchers have taken the first steps to treat Alzheimer's disease, Parkinson's disease and Type 2 diabetes b

Updated on:May 06,2024 14

Study shows INT-1B3 inhibits distant tumor metastasis and significantly prolongs survival

by Impact Journals LLCProposed mode of action of INT-1B3/1B3.INT-1B3/1B3 induces apoptosis and cell death leading to expression of DAMPs, e.g., expression of calreticulin, reduced expression of CD39 a

Updated on: August 27,2024 0

Study shows INT-1B3 inhibits distant tumor metastasis and significantly prolongs survival

by Impact Journals LLCProposed mode of action of INT-1B3/1B3.INT-1B3/1B3 induces apoptosis and cell death leading to expression of DAMPs, e.g., expression of calreticulin, reduced expression of CD39 a

Updated on:August 27,2024 0

A breast cancer drug, susceptible to resistance, can be restored to effectiveness, researchers demonstrate

by Leslie Cantu,Medical University of South CarolinaCredit: Pixabay/CC0 Public DomainIn a new paperpublishedinCancer Research, researchers at MUSC Hollings Cancer Center have s

Updated on: May 06,2024 14

A breast cancer drug, susceptible to resistance, can be restored to effectiveness, researchers demonstrate

by Leslie Cantu,Medical University of South CarolinaCredit: Pixabay/CC0 Public DomainIn a new paperpublishedinCancer Research, researchers at MUSC Hollings Cancer Center have s

Updated on:May 06,2024 14

Results of trial will help guide treatment of malignant bowel obstruction in patients with advanced cancer

by SWOG Cancer Research NetworkCredit: CC0 Public DomainFindings from the first-ever prospective trial including a randomized pathway comparing surgery to non-surgical treatment of malignant bowel obs

Updated on: January 04,2024 9

Results of trial will help guide treatment of malignant bowel obstruction in patients with advanced cancer

by SWOG Cancer Research NetworkCredit: CC0 Public DomainFindings from the first-ever prospective trial including a randomized pathway comparing surgery to non-surgical treatment of malignant bowel obs

Updated on:January 04,2024 9

Team reports on development of potential new generic treatment for multiple types of cancer

byRIKENA schematic of the study. The simple targeted alpha-particle therapy (TAT) compound was made by joining the radionuclide astatine-211 to an azide. The TAT compound was injected into a mic

Updated on: January 07,2024 5

Team reports on development of potential new generic treatment for multiple types of cancer

byRIKENA schematic of the study. The simple targeted alpha-particle therapy (TAT) compound was made by joining the radionuclide astatine-211 to an azide. The TAT compound was injected into a mic

Updated on:January 07,2024 5